Cite
MLA Citation
Brian G Feagan et al.. “Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.” Lancet gastroenterology and hepatology, vol. 8, 2023, pp. 307–320. http://access.bl.uk/ark:/81055/vdc_100180206238.0x000002